Multicomponent synthesis of [3,2-c]thienocoumarins and evaluation of their activity against Mycobacterium tuberculosis

- 342030
Abstract
Favorite this paper
How to cite this paper?
Abstract

Tuberculosis remains the leading cause of death among infectious diseases, causing an estimated 1.3 million deaths worldwide and surpassing COVID-19 and HIV. In 2023, approximately 10.6 million cases were reported, including diagnosed and undiagnosed infections, while 275.000 cases were drug-resistant, highlighting the urgent need for new therapies. Coumarins are natural products widely studied due to their diverse biological activities. Recent studies have shown that triazole and thiazole derivatives exhibit promising anti-tubercular activity, with minimum inhibitory concentrations (MICs) of 100 μM and 60 μM, respectively. In this work, a multicomponent synthesis was employed to access [3,2-c]thienocoumarins for evaluation against Mycobacterium tuberculosis. Using the Farapjour method, four analogs were obtained, with yields ranging from 8% to 31%. Biological screening approved TC-3 after screening, and MIC determination using the Resazurin Microtiter Assay is currently ongoing. Further analog synthesis and mechanistic studies are planned.

 

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade Federal de Santa Catarina
  • 2 Universidade Federal de Santa Catarina (UFSC)
  • 3 Polydoro Ernani de São Thiago University Hospital
Track
  • BMOS-2026
Keywords
Drug discovery
Multicomponent synthesis
Coumarin